Associate Director, Innovation ETCT, ADC

The Extracellular Targeted Cancer Therapeutics (ETCT) Biology Unit within the Oncology Research Unit is seeking an experienced Associate Director to contribute to internal and external facing initiatives designed to accelerate the build of a targeted biologics portfolio in Oncology. The candidate will collaborate with an experienced team of scientists and co-lead cross-functional initiatives to develop the next generation of ADCs. The successful applicant will have prior experience leading matrix teams with oversight of critical path chemistry and biology in the preclinical development of ADCs for cancer therapy.

Please note: This position requires an on-site office -based presence 2 to 3 days a week

Key Responsibilities:

As an Associate Director for Innovation in ETCT, your responsibilities will be to:

·       Lead discovery screening and early programs, specifically antibody drug conjugates (ADCs).

·       Collaborate with internal platform groups to deliver success on externally partnered programs and/or technologies.

·       Identify new areas for investment at the preclinical research phase, as well as contribute technical expertise to scientific due diligence review of in-licensing opportunities with the business development organization.

·       Collaborate internally and with business development to establish strategic partnerships and alliances with external organizations, including startups, research institutions, and pharmaceutical companies.

Why you?

Required Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• PhD in Cancer Biology, Pharmacology, Cellular Biology, or related life science field with 4+ years of postdoctoral, pharmaceutical or biotechnology industry experience, or MS in Cancer Biology, Pharmacology, Cellular Biology, or related life science fields with 7+ years of pharmaceutical or biotechnology industry experience.
• Experience leading cross-functional drug discovery project teams to develop novel therapeutic platforms for biologics targets.
• Direct experience developing and progressing ADC, from concept to candidate selection and supporting critical path mechanistic biology and chemistry.

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• 7+ years pharmaceutical or biotechnology industry research and leadership experience in preclinical oncology biologics drug discovery.
• Prior experience optimizing ADC warhead-linker-payload chemistry.
• Experience working with business development to perform due diligence on oncology assets
• Strong organizational and interpersonal skills and the ability to work independently.
• Excellent communication and collaboration skills, with a proven track record of working effectively in a multidisciplinary environment.

• If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $136,500 to $227,500. • If you are based in another US location, the annual base salary range is $136,500 to $227,500. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave. If salary ranges are not displayed in the job posting for a specific country, the relevant compensation will be discussed during the recruitment process.

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?
Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahe